What did @its.that.girl.tash actually say?
After emergency back surgery, the creator says she injected BPC-157 (which she calls "VPC 157") daily at 500 mcg for eight weeks, alongside TB-500 twice weekly at 2.5 mg. She credits both peptides with dramatically faster recovery and reduced scarring. She also makes a pointed safety note: get bloodwork done first, because these peptides might "fast track" abnormal cells. That last part is more responsible than most peptide content you'll see on TikTok, and it's worth acknowledging. However, she also says these are "very well researched" and that BPC-157 can be prescribed by a doctor, both of which need unpacking. The dosing she describes, the injection-site protocol, and the wound-healing claims are specific enough to fact-check against the actual literature, so that's what we're going to do.
Does the science back this up?
The animal data on BPC-157 is genuinely interesting, but calling it "very well researched" for humans is a stretch. Most of the evidence is preclinical. TB-500 has a similar problem. Here's where things actually stand.
BPC-157 is a synthetic peptide derived from a protein found in gastric juice. In rodent models, it has shown effects on tendon repair, muscle healing, and wound closure, often through upregulation of growth hormone receptors and nitric oxide pathways (Sikiric et al., 2018, Current Pharmaceutical Design). The wound-healing claim has some basis here. A 2021 review in Biomedicines noted BPC-157 accelerated skin wound closure in animal studies, but the authors explicitly flagged the absence of human clinical trials.
TB-500 is a synthetic version of thymosin beta-4, a peptide involved in actin regulation and cell migration. Animal studies show it supports tissue repair and reduces inflammation (Goldstein & Kleinman, 2015, Annals of the New York Academy of Sciences). Again, no randomized controlled trials in humans exist for surgical recovery.
So the science is suggestive, not conclusive. Calling these peptides "very well researched" overstates where the evidence actually is.
What did they get wrong (or right)?
Let's be direct. The creator got the cancer risk flag roughly right, and that matters. BPC-157 and TB-500 both influence angiogenesis and cell proliferation pathways. If abnormal cells are present, pro-growth signaling is a legitimate concern, not a fringe idea. A 2022 commentary in Cancer Research flagged thymosin beta-4 overexpression as a factor in tumor progression in certain cell lines. The creator's advice to get bloodwork done first is sound, even if her explanation was vague.
What she got wrong, or at least oversimplified:
- Calling these peptides "very well researched" is misleading. The human clinical trial data is essentially nonexistent for surgical recovery applications.
- Recommending injection near the injury site as a blanket protocol ignores the fact that injection-site guidance for compounded peptides is not standardized and carries infection risk if not done under clinical supervision.
- The claim that BPC-157 can be prescribed by a doctor is technically true in some jurisdictions via compounding pharmacies, but it is not FDA-approved, and compounded versions vary significantly in quality and concentration.
- Attributing her faster recovery and reduced scarring solely to these peptides ignores confounders like surgical quality, post-op physical therapy, nutrition, sleep, and individual variation.
What should you actually know?
If you're considering BPC-157 or TB-500 after surgery or injury, the conversation starts with your surgeon and a physician who understands peptide therapy, not a TikTok video. That's not a dismissal of the creator's experience. It's a recognition that n=1 anecdotes, even well-intentioned ones, cannot account for your specific health status, surgical context, or risk factors.
The cancer risk point the creator raises is real enough to take seriously. Both BPC-157 and TB-500 work partly through pathways that promote cell growth and vascularization. That's why they might help healing. It's also why using them without knowing your baseline health status, particularly any history of or predisposition to cancer, is not a casual decision.
TB-500 is not approved for human use and is not available by prescription in most countries. BPC-157 exists in a regulatory gray zone, available through compounding pharmacies in some regions but without FDA approval for any indication. Quality control across sources varies enormously. If you're going to explore this, a regulated telehealth provider who can order labs, review your history, and monitor your response is the appropriate starting point, not a supplier you found after watching a 90-second video.